Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus TYLENOL W CODEINE NO 3.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus TYLENOL W CODEINE NO 3.
METHADOSE vs TYLENOL W/ CODEINE NO. 3
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Codeine is a prodrug converted to morphine, which acts as a mu-opioid receptor agonist; acetaminophen inhibits cyclooxygenase (COX) and modulates cannabinoid and serotonergic pathways, with central analgesic effect.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
1-2 tablets (300 mg acetaminophen/30 mg codeine per tablet) orally every 4 hours as needed for pain; maximum 12 tablets per day.
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Acetaminophen: 2-3 hours (prolonged in hepatic or renal impairment, overdose). Codeine: 2.5-3.5 hours; morphine from codeine: approx 2 hours; prolonged in hepatic or renal impairment.
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Acetaminophen: primarily renal (hepatic metabolism followed by renal excretion of metabolites; <5% unchanged). Codeine: renal (primarily as codeine and its metabolites, including morphine, norcodeine, and conjugated forms; 90% excreted in urine, 10% in feces).
Category C
Category D/X
Opioid Agonist
Opioid Agonist